Fox Chase Cancer Center — Rockledge, Pennsylvania

Fox Chase Cancer Center is a clinical research site located in Rockledge, Pennsylvania, United States 19046.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Fox Chase Cancer Center has participated in 8 clinical trials.

Therapeutic areas: Advanced Solid Tumors, Lymphoma, EGFR Inhibitor-associated Rash.

Sponsors: Millennium Pharmaceuticals, Inc., Spectrum Pharmaceuticals, Inc, Fox Chase Cancer Center.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fox Chase Cancer Center?

Fox Chase Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fox Chase Cancer Center conducted?

Fox Chase Cancer Center has 8 clinical trials on record. Their work covers Advanced Solid Tumors, Lymphoma, EGFR Inhibitor-associated Rash.

Is Fox Chase Cancer Center accredited by Crixeo Health?

Yes — Fox Chase Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Fox Chase Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.